From Wikipedia, the free encyclopedia
An antiplatelet drug is a member of a class of pharmaceuticals that decreases platelet aggregation and inhibits thrombus formation. They are effective in the arterial circulation, where anticoagulants have little effect.
They are widely used in primary and secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
[edit] Choice of antiplatelet drug
A recent review [1] states: "....low-dose aspirin increases the risk of major bleeding 2-fold compared with placebo. However, the annual incidence of major bleeding due to low-dose aspirin is modest—only 1.3 patients per thousand higher than what is observed with placebo treatment. Treatment of approximately 800 patients with low-dose aspirin annually for cardiovascular prophylaxis will result in only 1 additional major bleeding episode."
[edit] Antiplatelet drugs
The most important antiplatelet drugs are:
[edit] See also
Antithrombotics (thrombolytics, anticoagulants, and antiplatelet drugs) (B01) |
Vitamin K antagonists |
Acenocoumarol, Clorindione, Dicumarol (Dicoumarol), Diphenadione, Ethyl biscoumacetate, Phenprocoumon, Phenindione, Tioclomarol, Warfarin |
Heparin group
(Platelet aggregation inhibitors) |
Antithrombin III, Bemiparin, Dalteparin, Danaparoid, Enoxaparin, Heparin, Nadroparin, Parnaparin, Reviparin, Sulodexide, Tinzaparin |
Other platelet
aggregation inhibitors |
Abciximab, Acetylsalicylic acid (Aspirin), Aloxiprin, Beraprost, Ditazole, Carbasalate calcium, Cloricromen, Clopidogrel, Dipyridamole,Eptifibatide, Indobufen, Iloprost, Picotamide, Prasugrel,Prostacyclin, Ticlopidine, Tirofiban, Treprostinil, Triflusal |
Enzymes |
Alteplase, Ancrod, Anistreplase, Brinase, Drotrecogin alfa, Fibrinolysin, Protein C, Reteplase, Saruplase, Streptokinase, Tenecteplase, Urokinase |
Direct thrombin inhibitors |
Argatroban, Bivalirudin,Dabigatran, Desirudin, Hirudin, Lepirudin, Melagatran, Ximelagatran |
Other antithrombotics |
Defibrotide, Dermatan sulfate, Fondaparinux, Rivaroxaban |
Non-medicinal |
Citrate, EDTA, Oxalate |
Major Drug Groups |
Brain and Nervous system |
Analgesics, Anesthetics, Anxiolytics, Antidepressants, Antipsychotics, Anticonvulsants, Nervous system stimulants, Antiemetics, Hallucinogens, Mood stabilizers |
Respiratory system |
Bronchodilators, Decongestants |
Heart and Circulation |
Angiotensin converting enzyme inhibitors, Antiarrhythmics, Antianginals, Antihypertensives, Antihyperlipidemics, Anticoagulants, Antiplatelets, Beta blockers, Diuretics, Thrombolytics, Vasodilators |
Gastrointestinal tract |
Antacids, Antidiarrhoeals, H2-receptor antagonists, Proton pump inhibitors, Laxatives |
Muscles, Bones, and Joints |
Anti-inflammatories, Antirheumatics, Corticosteroids, Muscle relaxants |
Allergy |
Antihistamines |
Infections and Infestations |
Antibiotics, Antivirals, Vaccines, Antiprotozoals, Antifungals, Anthelmintics |
Endocrine system |
Corticosteroids, Anti-diabetics |
Malignant and Immune disease |
Anticancer agents, Immunosuppressants |
Reproductive system |
Hormonal contraception, Fertility agents, Selective estrogen receptor modulators |
Skin |
Antipruritics |